GT Biopharma, Inc. (GTBP) Tops Q3 EPS by 3c

GT Biopharma, Inc. (NASDAQ: GTBP) reported Q3 EPS of ($0.06), $0.03 better than the analyst estimate of ($0.09).

For earnings history and earnings-related data on GT Biopharma, Inc. (GTBP) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• Robinhood prices $2B convertible notes offering due 2029
• MP Materials seen largely insulated after China export-control move